AzTrials
AzTrials

Emotional DistressBEAMNCT06713460

Emotional Intelligence Intervention to Improve Mental Well-Being of Adolescents With Emotional Distress (BEAM)

A study testing BEAM in people with Emotional Distress, run by Consorci Sanitari de Terrassa at 2 sites in Spain.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to assess the effectiveness of a multicomponent intervention in adolescents with emotional distress. The main question it aims to answer is: Does the intervention increase mental well-being, emotional resilience, and emocional intelligence in adolescents with emotional distress?… Read more about this study

Who is it for?
Ages 14 to 16 years
Conditions the study is for
Emotional Distress
What is being tested?
BEAM
Could I receive a placebo?
No, everyone receives an active treatment
How many people
104 participants
Where
2 sitesSpain
Study dates
7 Apr 2025to 30 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Adolescents with emotional distress scores on the Warwick-Edinburgh Mental Well- being Scale.
  • Adolescents aged 14-16 ( in 9th Grade).
  • Informed consent form signed (by adolescents and their parent or legal guardian)

Who cannot join

  • Physical illnesses that prevent attendance at scheduled sessions, severe mental disorders (such as Autism Spectrum Disorder, major depression, schizophrenia).
  • No comprehension of the language
  • Lack of consent from the adolescents or their parents or legal guardians

Trial locations and contacts

2 sites in 1 country.

Spain2 sites

  • Consorci Sanitari de Terrassa

    Terrassa, Barcelona, 08227

  • Institut Can Roca

    Terrassa, Barcelona, 08227

Other trials in Spain

About this study

Official title: Emotional Intelligence Intervention to Improve Mental Well-Being of Adolescents With Emotional Distress (BEAM): Study Protocol for a Randomized Controlled Trial

The goal of this clinical trial is to assess the effectiveness of a multicomponent intervention in adolescents with emotional distress. The main question it aims to answer is:

Does the intervention increase mental well-being, emotional resilience, and emocional intelligence in adolescents with emotional distress?

Participants will:

  • Participate in a multi-component intervention for 9 weeks at school.
Read the detailed description

Background:Adolescence involves biological, psychological and social transformations that increase vulnerability to mental health problems. Emotional intelligence is a protective factor that improves mental well-being. Given the sensitivity of adolescence to mental health disorders, emotional intelligence emerges as a valuable tool for promoting mental well-being.The investigators hypothesize that adolescents aged 14-16 with emotional distress who receive the multicomponent intervention based on emotional intelligence will obtain better scores on the Warwick-Edinburgh Mental Well-being Scale compared to the control group, after the intervention and at 24 weeks post-intervention.

Method :The study is a Randomized Controlled Trial (RCT). The participants and their parents will sign an agreement to participate in the study and will be randomly allocated in control and intervention groups by external researcher using a computer-generated random number. The intervention will be conducted in a school setting during the 2025-2026 academic year. It will comprise a multicomponent program consisting of nine sessions, each lasting 55 minutes, addressing various topics related to emotional intelligence. Data will be collected from April 2026 to december 2026."Three psychometric scales will be used: Warwick-Edinburgh Mental Wellbeing Scale (WEMWB), Trait Meta-Mood Scale (TMMS-24) and Child Youth Resilience Measure (CYRM-32), with measurements before the intervention (T0), 9 (T1) and 24 weeks follow-up (T2).The group receiving the intervention is expected to show improvements in emotional well-being, emotional intelligence and resilience compared to the control group.

Accepting an alpha risk of 0.05 and a beta risk of 0.20 in a bilateral contrast, 52 subjects in the first group and 52 in the second group are required to detect a difference equal to or greater than 5 units on the WEMWBS scale. A common standard deviation of 6.8 is assumed. A loss to follow-up rate of 0.1 (10%) and a correlation between observations of 0.4 was estimated.

Being tested
BEAM
Keywords
Mental Well-being, Emotional Intelligence, Emotional Distress, Adolescents
Medical subject headings
Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BEAMBehavioural

    Multicomponent intervention

Study groups in NCT06713460
Study groupRoleWhat they receive
Intervention group (multicomponent intervention)ExperimentalA multi-component group intervention, based on Mayer and Salovey's emotional skills model, will target adolescents with emotional distress. Led by the Community Emotional Well-Being Coordinator and supported by a nurse, physiotherapist, and educational psychologist, the intervention will occur during the 2025-2026 academic year in Consorci Sanitari de Terrassa institutes. It will consist of nine 55-minute sessions during school hours, supplemented by voluntary home activities. The program will focus on emotional identification and regulation, structured around seven components: goal-setting, positive thinking, self-awareness, self-esteem, willpower, mindfulness, and assertiveness.
Receives: Behavioral: BEAM
Control group (non intervention)No interventionParticipants in the control group will complete the same research questionnaires as the intervention group during the same period. Control group participants will undergo the intervention (if effective) in the following academic year (January - June 2027), when they are in 10th Grade.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Improve well-being

    Changes in level of well-being using the Warwick-Edinburgh Mental Well-Being Scale (WEMWBS). Values range from 14 to 70 . Higher scores, better outcome.

    Measured: Baseline (T0), post-intervention (9 weeks) (T1), and 24 weeks follow-up (T2)

Secondary outcomes (2)

  1. Increased resilience

    Changes in level of resilience using the Child Youth Resilience Measure -32. Values range from 32 to 160 . Higher scores, better outcome.

    Measured: Baseline (T0), post-intervention (9 weeks) (T1), and 24 weeks follow-up (T2)

  2. Increase emotional intelligence

    Changes in level of emotional intelligence using the Trait Meta-Mood Scale (TMMS). The TMMS-24 contains three key dimensions of EI with 8 items each: Emotional Attention: Adequate values: Males (22 to 32); Females (25 to 35); Emotional clarity: excellent values: Males (> 36); Females (>35), and Emotional repair: excellent values: Men (> 36); Women (>35)).

    Measured: Baseline (T0), post-intervention (9 weeks) (T1), and 24 weeks follow-up (T2)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Dec 2024
  2. Study start7 Apr 2025
  3. Primary completion30 Sep 2026 (estimated)
  4. Study completion30 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly assigned to either the control or intervention group by an external investigator through computer-generated random numbers.
Masking
None (open label)
Enrolment
104 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06713460
Sponsor's protocol ID
01-24-1CR-102
Acronym
BEAM
Status last verified
May 2026
First submitted
27 Nov 2024
Last updated
14 May 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Fully anonymised overall results will be shared.

Publications

  • Gracia R, Pamias M, Mortier P, Alonso J, Perez V, Palao D. Is the COVID-19 pandemic a risk factor for suicide attempts in adolescent girls? J Affect Disord. 2021 Sep 1;292:139-141. doi: 10.1016/j.jad.2021.05.044. Epub 2021 May 27.

    PubMed 34119869

  • Llistosella M, Gutierrez-Rosado T, Rodriguez-Rey R, Liebenberg L, Bejarano A, Gomez-Benito J, Limonero JT. Adaptation and Psychometric Properties of the Spanish Version of Child and Youth Resilience Measure (CYRM-32). Front Psychol. 2019 Jun 28;10:1410. doi: 10.3389/fpsyg.2019.01410. eCollection 2019.

    PubMed 31316419

  • Salguero, J. M., Fernández-Berrocal, P., Balluerka, N., & Aritzeta, A. (2010). Measuring perceived emotional intelligence in the adolescent population: Psychometric properties of the Trait Meta-Mood Scale. Social Behavior and Personality: an international journal, 38(9), 1197-1209

  • Castellvi P, Forero CG, Codony M, Vilagut G, Brugulat P, Medina A, Gabilondo A, Mompart A, Colom J, Tresserras R, Ferrer M, Stewart-Brown S, Alonso J. The Spanish version of the Warwick-Edinburgh mental well-being scale (WEMWBS) is valid for use in the general population. Qual Life Res. 2014 Apr;23(3):857-68. doi: 10.1007/s11136-013-0513-7. Epub 2013 Sep 5.

    PubMed 24005886

  • Dominguez-Garcia E, Fernandez-Berrocal P. The Association Between Emotional Intelligence and Suicidal Behavior: A Systematic Review. Front Psychol. 2018 Nov 30;9:2380. doi: 10.3389/fpsyg.2018.02380. eCollection 2018.

    PubMed 30555393

  • Pedrosa-Vazquez C, Ayuso-Marganon R, Lidon-Moyano C, Morales P, Canas L, Garriga-Salvo C, Farfan-Dominguez B, Rey-Vito S, Llistosella M. Emotional intelligence intervention to improve mental well-being of adolescents with emotional distress (BEAM): study protocol for a randomised controlled trial. BMJ Open. 2026 May 8;16(5):e118438. doi: 10.1136/bmjopen-2026-118438.

    PubMed 42103371

Questions about this trial

What is this clinical trial studying?

A study testing BEAM in people with Emotional Distress, run by Consorci Sanitari de Terrassa at 2 sites in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 14 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Improve well-being (time frame: Baseline (T0), post-intervention (9 weeks) (T1), and 24 weeks follow-up (T2)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06713460, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 May 2026.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in